{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T04:39:38Z","timestamp":1769056778582,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1007\/s11882-008-0011-0","type":"journal-article","created":{"date-parts":[[2008,1,29]],"date-time":"2008-01-29T12:08:54Z","timestamp":1201608534000},"page":"56-62","source":"Crossref","is-referenced-by-count":36,"title":["Hypersensitivity reactions to oxaliplatin and other antineoplastic agents"],"prefix":"10.1007","volume":"8","author":[{"given":"Ekaterini","family":"Syrigou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kostas","family":"Syrigos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Wasif","family":"Saif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,1,30]]},"reference":[{"key":"11_CR1","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1385\/CRIAI:24:3:253","volume":"24","author":"G.M. Shepherd","year":"2003","unstructured":"Shepherd GM: Hypersensitivity reactions to chemotherapeutic drugs. Clin Rev Allergy Immunol 2003, 24:253\u2013262.","journal-title":"Clin Rev Allergy Immunol"},{"key":"11_CR2","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1006\/gyno.2001.6331","volume":"82","author":"J.B. Robinson","year":"2001","unstructured":"Robinson JB, Singh D, Bodurka-Bevers DC, et al.: Hypersensitivity reactions and the utility of oral and intravenous desensitization in patients with gynecologic malignancies. Gynecol Oncol 2001, 82:550\u2013558.","journal-title":"Gynecol Oncol"},{"issue":"2Suppl","key":"11_CR3","doi-asserted-by":"crossref","first-page":"S548","DOI":"10.1067\/mai.2003.93","volume":"111","author":"R.S. Gruchalla","year":"2003","unstructured":"Gruchalla RS: Drug allergy. J Allergy Clin Immunol 2003, 111(2 Suppl):S548\u2013S559.","journal-title":"J Allergy Clin Immunol"},{"key":"11_CR4","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1200\/JCO.2003.11.126","volume":"21","author":"M.L. Rothenberg","year":"2003","unstructured":"Rothenberg ML, Oza AM, Bigelow RH, et al.: Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial. J Clin Oncol 2003, 21:2059\u20132069.","journal-title":"J Clin Oncol"},{"key":"11_CR5","first-page":"253","volume":"22","author":"A. Gramont De","year":"2003","unstructured":"De Gramont A, Banzi M, Navarro M, et al.: Oxaliplatin\/5-FU\/LV in adjuvant colon cancer: results of the international randomized mosaic trial. Proc Am Soc Clin Oncol 2003, 22:253.","journal-title":"Proc Am Soc Clin Oncol"},{"key":"11_CR6","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.ejca.2005.06.021","volume":"41","author":"F. Maindrault-Goebel","year":"2005","unstructured":"Maindrault-Goebel F, Andre T, Tournigand C, et al.: Allergic-type reactions to oxaliplatin: retrospective analysis of 42 patients. Eur J Cancer 2005, 41:2262\u20132267.","journal-title":"Eur J Cancer"},{"key":"11_CR7","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1002\/cncr.11379","volume":"97","author":"R.R. Thomas","year":"2003","unstructured":"Thomas RR, Quinn MG, Schuler B, et al.: Hypersensitivity and idiosyncratic reactions to oxaliplatin. Cancer 2003, 97:2301\u20132307.","journal-title":"Cancer"},{"key":"11_CR8","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/annonc\/mdl116","volume":"17","author":"R.S. Vries De","year":"2006","unstructured":"De Vries RS, Mattijssen EJ, van Sorge AA: Serious delayed hypersensitivity reaction to oxaliplatin. Ann Oncol 2006, 17:1723\u20131724.","journal-title":"Ann Oncol"},{"key":"11_CR9","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1023\/A:1011161126611","volume":"12","author":"M. Stahl","year":"2005","unstructured":"Stahl M, Koster W, Wilke H: Reaction after oxaliplatin-prevention with corticosteroids. Ann Oncol 2005, 12:874.","journal-title":"Ann Oncol"},{"key":"11_CR10","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1023\/A:1008366223918","volume":"12","author":"D. Santini","year":"2005","unstructured":"Santini D, Tonini G, Salerno A, et al.: Idiosyncratic reactions after oxaliplatin infusion. Ann Oncol 2005, 12:132\u2013133.","journal-title":"Ann Oncol"},{"key":"11_CR11","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1164\/ajrccm.160.2.9807065","volume":"160","author":"A.J. Newman Taylor","year":"1991","unstructured":"Newman Taylor AJ, Cullinan P, Lympany PA, et al.: Interaction of HLA phenotype and exposure intensity in sensitization to complex platinum salts. Am J Resp Crit Care Med 1991, 160:435\u2013438.","journal-title":"Am J Resp Crit Care Med"},{"key":"11_CR12","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0140-6736(02)08158-8","volume":"359","author":"S. Hetherington","year":"2002","unstructured":"Hetherington S, Hughes AR, Mosteller M, et al.: Genetic variations in HLA-B region and hypersensitivity reactions to abacavir. Lancet 2002, 359:1121\u20131122.","journal-title":"Lancet"},{"key":"11_CR13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/cncr.11901","volume":"100","author":"P. Bhargava","year":"2004","unstructured":"Bhargava P, Gammon D, McCormick MJ: Hypersensitivity and idiosyncratic reactions to oxaliplatin. Cancer 2004, 100:211\u2013212.","journal-title":"Cancer"},{"key":"11_CR14","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/sj.bjc.6601155","volume":"89","author":"G. Brandi","year":"2003","unstructured":"Brandi G, Pantaleo MA, Galli C, et al.: Hypersensitivity reactions related to oxaliplatin (OHP). Br J Cancer 2003, 89:477\u2013481.","journal-title":"Br J Cancer"},{"key":"11_CR15","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1200\/JCO.2002.20.4.1146","volume":"20","author":"L. Meyer","year":"2002","unstructured":"Meyer L, Zuberbier T, Worm M, et al.: Hypersensitivity reactions to oxaliplatin: cross-reactivity to carboplatin and the introduction of a desensitization schedule. J Clin Oncol 2002, 20:1146\u20131147.","journal-title":"J Clin Oncol"},{"key":"11_CR16","first-page":"789","volume":"22","author":"K.M. Qureshi","year":"2003","unstructured":"Qureshi KM: Incidence of hypersensitivity reactions to oxaliplatin at Roswell Park Cancer Institute (RPCI) and protocol for desensitization. Proc Am Soc Clin Oncol 2003, 22:789.","journal-title":"Proc Am Soc Clin Oncol"},{"key":"11_CR17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/annonc\/mdj042","volume":"17","author":"S.W. Siu","year":"2005","unstructured":"Siu SW, Chan RT, Au GK: Hypersensitivity reactions to oxaliplatin: experience in a single institute. Ann Oncol 2005, 17:259\u2013261.","journal-title":"Ann Oncol"},{"key":"11_CR18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00520-006-0107-9","volume":"15","author":"M.Y. Lee","year":"2007","unstructured":"Lee MY, Yang MH, Liu JH, et al.: Severe anaphylactic reactions in patients receiving oxaliplatin therapy: a rare but potentially fatal complication. Support Care Cancer 2007, 15:89\u201393.","journal-title":"Support Care Cancer"},{"key":"11_CR19","unstructured":"Eloxatin (oxaliplatin injection) [package insert]. Bridgewater, NJ: Sanofi Aventis US; 2007. Available at: www.eloxatin.com."},{"key":"11_CR20","first-page":"327","volume":"16","author":"T. Herrero","year":"2006","unstructured":"Herrero T, Tornero P, Infante S, et al.: Diagnosis and management of hypersensitivity reactions caused by oxaliplatin. J Investig Allergol Clin Immunol 2006, 16:327\u2013330.","journal-title":"J Investig Allergol Clin Immunol"},{"key":"11_CR21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000012159","volume":"59","author":"H. Ulrich-Pur","year":"2000","unstructured":"Ulrich-Pur H, Penz M, Fiebiger WC, et al.: Oxaliplatin-induced fever and release of IL-6. Oncology 2000, 59:187\u2013189.","journal-title":"Oncology"},{"key":"11_CR22","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jaci.2005.12.1303","volume":"117","author":"H.A. Sampson","year":"2006","unstructured":"Sampson HA, Mu\u00f1oz-Furlong A, Campbell RL, et al.: Second symposium on the definition and management of anaphylaxis: summary report\u2014Second National Institute of Allergy and Infectious Disease\/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006, 117:391\u2013397.","journal-title":"J Allergy Clin Immunol"},{"key":"11_CR23","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1634\/theoncologist.12-5-601","volume":"12","author":"H.J. Lenz","year":"2007","unstructured":"Lenz HJ: Management and preparedness for infusion and hypersensitivity reactions. Oncologist 2007, 12:601\u2013609.","journal-title":"Oncologist"},{"key":"11_CR24","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1345\/aph.1E631","volume":"39","author":"V.T. Christina","year":"2005","unstructured":"Christina VT: Hypersensitivity reactions to oxaliplatin in two Asian patients. Ann Pharmacother 2005, 39:1114\u20131118.","journal-title":"Ann Pharmacother"},{"key":"11_CR25","doi-asserted-by":"crossref","first-page":"767","DOI":"10.2165\/00002018-200124100-00005","volume":"24","author":"K.M. Zanotti","year":"2001","unstructured":"Zanotti KM, Markman M: Prevention and management of antineoplasticinduced hypersensitivity reactions. Drug Saf 2001, 24:767\u2013779.","journal-title":"Drug Saf"},{"key":"11_CR26","first-page":"161","volume":"15","author":"I.D. Gonzales","year":"2000","unstructured":"Gonzales ID, Saez RS, Rodilla EM, et al.: Hypersensitivity reactions to chemotherapy drugs. Alergol Immunol Clin 2000, 15:161\u2013181.","journal-title":"Alergol Immunol Clin"},{"key":"11_CR27","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jaci.2006.11.640","volume":"119","author":"V. Leguy-Seguin","year":"2007","unstructured":"Leguy-Seguin V, Jolimoy G, Coudert B, et al.: Diagnostic and predictive value of skin testing in platinum salt hypersensitivity. J Allergy Clin Immunol 2007, 119:726\u2013730.","journal-title":"J Allergy Clin Immunol"},{"key":"11_CR28","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1200\/JCO.2001.19.12.3126","volume":"19","author":"K. Zanotti","year":"2001","unstructured":"Zanotti K, Rybicki L, Kennedy A, et al.: Carboplatin skin testing: a skin-testing protocol for predicting hypersensitivity to carboplatin chemotherapy. J Clin Oncol 2001, 19:3126\u20133129.","journal-title":"J Clin Oncol"},{"key":"11_CR29","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1200\/JCO.2003.05.539","volume":"21","author":"M. Markman","year":"2003","unstructured":"Markman M, Zanotti K, Peterson G, et al.: Expanded experience with an intradermal skin test to predict for the presence or absence of carboplatin hypersensitivity. J Clin Oncol 2003, 21:4611\u20134614.","journal-title":"J Clin Oncol"},{"key":"11_CR30","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/annonc\/mdg092","volume":"14","author":"C. Garufi","year":"2003","unstructured":"Garufi C, Cristaudo A, Vanni B, et al.: Skin testing and hypersensitivity reactions to oxaliplatin. Ann Oncol 2003, 14:497\u2013498.","journal-title":"Ann Oncol"},{"key":"11_CR31","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1345\/aph.1E532","volume":"39","author":"L. Mis","year":"2005","unstructured":"Mis L, Fernando NH, Hurwitz HI, Morse MA: Successful desensitization to oxaliplatin. Ann Pharmacother 2005, 39:966\u2013968.","journal-title":"Ann Pharmacother"},{"key":"11_CR32","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/01.pap.0000249924.90645.5b","volume":"14","author":"D.A. Edmondson","year":"2007","unstructured":"Edmondson DA, Gruling BJ, Urmanski AM, et al.: Oxaliplatin hypersensitivity: case report and successful repeat desensitization. Am J Ther 2007, 14:116\u2013118.","journal-title":"Am J Ther"},{"key":"11_CR33","first-page":"249","volume":"1","author":"M.W. Saif","year":"2005","unstructured":"Saif MW, Reardon J: Management of oxaliplatin-induced peripheral neuropathy. Ther Clin Risk Manage 2005, 1:249\u2013258.","journal-title":"Ther Clin Risk Manage"},{"key":"11_CR34","first-page":"576","volume":"4","author":"M.W. Saif","year":"2004","unstructured":"Saif MW: Oral calcium ameliorating oxaliplatin-induced peripheral neuropathy. J Applied Res 2004, 4:576\u2013582.","journal-title":"J Applied Res"},{"key":"11_CR35","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1517\/14740338.5.5.687","volume":"5","author":"M.W. Saif","year":"2006","unstructured":"Saif MW: Hypersensitivity reactions associated with oxaliplatin. Expert Opin Drug Saf 2006, 5:687\u2013694.","journal-title":"Expert Opin Drug Saf"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-008-0011-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11882-008-0011-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-008-0011-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T23:42:17Z","timestamp":1559432537000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11882-008-0011-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["11"],"URL":"https:\/\/doi.org\/10.1007\/s11882-008-0011-0","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}